Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 4Phase 1/2 2Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 59Neoplasms 23Prostatic Neoplasms 21Multiple Myeloma 18Carcinoma, Hepatocellular 15Carcinoma, Non-Small-Cell Lung 14Stomach Neoplasms 11Papillomavirus Infections 11Lung Neoplasms 11Colorectal Neoplasms 10Melanoma 9Neoplasm Metastasis 7Leukemia, Myeloid, Acute 7Waldenstrom Macroglobulinemia 6Pain, Postoperative 6Lymphoma, Non-Hodgkin 6Leiomyoma 6Hematologic Neoplasms 6Brain Neoplasms 6Thyroid Neoplasms 5Smoking Cessation 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Polycystic Ovary Syndrome 5Lymphoma 5Glioma 5Carcinoma, Renal Cell 5Venous Thromboembolism 4Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Tobacco Use Disorder 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hemangiosarcoma × 1 year × Clear all
NCT02625389 2025-10-10

A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

Guerbet

Phase 4 Completed
132 enrolled 9 charts
Sarcoma

Arteriovenous Malformations, Hemangioendothelioma, Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡